Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06547619 · ClinicalTrials.gov registry record · Early Phase 1

Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM

A Early Phase 1 study of Physical Inactivity and Endothelial Dysfunction, sponsored by Anna Stanhewicz, PhD.

Recruiting
Registry status
Early Phase 1
Development phase
40
Enrollment target
1
Study location

NCT06547619: Recruiting Early Phase 1 study of Physical Inactivity and Endothelial Dysfunction, sponsored by Anna Stanhewicz, PhD.

NCT06547619 is a Early Phase 1 study of Physical Inactivity and Endothelial Dysfunction that is actively recruiting participants, run by Anna Stanhewicz, PhD. The registered enrollment target is 40 participants, below the 224-participant average among 59 other Physical Inactivity trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06547619, a Early Phase 1 study of Physical Inactivity and Endothelial Dysfunction, is actively recruiting participants, sponsored by Anna Stanhewicz, PhD.

RECRUITING
Registry status
Early Phase 1
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD morbidity, particularly, within the first decade postpartum. GDM is associated with impaired endothelial function during pregnancy and decrements in macro- and microvascular function persist postpartum, despite the remission of insulin resistance following delivery. Collectively, while the association between GDM and elevated lifetime CVD risk is clear, and available evidence demonstrates a link between GDM and vascular dysfunction in the decade following pregnancy, the mechanisms mediating this persistent dysfunction remain unexamined. The purpose of this investigation is to examine the role of endothelin-1, a potent vasoconstrictor, in aberrant microvascular function in otherwise healthy women with a history of GDM and to identify whether this mechanism is influenced by physical activity and sedentary behavior.

Primary Outcome

cutaneous vascular vasodilator responses to insulin perfusion in lactated Ringer's, BQ 788 and BQ-123, and L-NAME treated microdialysis sites

Interventions

  • DRUG Insulin aspart

Study Locations (1)

Iowa

  • University of Iowa - Iowa City

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2024-10-01
Est. Completion 2027-05
Phase Early Phase 1
Anna Stanhewicz, PhD

14 total trials

What NCT06547619 shows while recruiting

NCT06547619 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 224-participant average among 59 other Physical Inactivity trials with a reported enrollment target (82% lower).

The record links to 3 conditions, with Physical Inactivity appearing as the primary indexed condition, and to 1 intervention - of which Insulin aspart is the first listed.

NCT06547619 reports a single indexed study location in Iowa.

Frequently Asked Questions

What is clinical trial NCT06547619 about?

NCT06547619 is a clinical study titled "Role of ET-1, Physical Activity, and Sedentary Behavior in Microvascular Dysfunction Following GDM". Women with a history of gestational diabetes mellitus (GDM) are at a 2-fold greater risk for the development of overt cardiovascular disease (CVD) following the effected pregnancy. While subsequent development of type II diabetes elevates this risk, prior GDM is an independent risk factor for CVD mo...

What is the current status of trial NCT06547619?

This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2024-10-01. Estimated completion is 2027-05.

What conditions does trial NCT06547619 study?

This clinical trial studies the following conditions: Physical Inactivity, Endothelial Dysfunction, Gestational Diabetes.

What interventions are being tested in trial NCT06547619?

The interventions under investigation include: Insulin aspart (DRUG).

Who is sponsoring clinical trial NCT06547619?

This trial is sponsored by Anna Stanhewicz, PhD, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06547619 being conducted?

This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Physical Inactivity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06547619's enrollment target sits among peer trials

40 47th of 59 higher than 9 of 59 other Physical Inactivity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Physical Inactivity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06547619, the US trial registry maintained by the National Library of Medicine. NCT06547619 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.